General information about the IGBC patients
Of the 7917 patients, 3 patients with polypoid lesions, 3 with biliary pancreatitis, 2 with cholecystitis, 14 with cholecystocholedocholithiasis and 27 with gallbladder stone diseases were diagnosed with IGBCs intraoperatively and(or) postoperatively. Among them, 13 were males and 36 were females, with the age range from 48 to 89 (Table 2).
Table 2
Baseline characteristics of the IGBCs
Parameter
|
Number (%)
|
Sex
Female
male
|
36(73.5)
13(26.5)
|
Age
≤60
>60
|
16(32.7)
33(67.3)
|
Presenting complaints
Abdominal pain
Jaundice
NONE
|
39(79.9)
3(6.1)
7(14.0)
|
Preoperative diagnosis
Cholecystitis
Gallbladder polyps
Gallbladder stones
Biliary pancreatitis
Cholecystocholedocholithiasis
|
2(4.1)
3(6.1)
27(55.1)
3(6.1)
14(28.6)
|
Incidence Of Igbcs In Different Gallbladder Diseases
The incidence of IGBCs in polypoid lesions, biliary pancreatitis, cholecystitis, cholecystocholedocholithiasis and gallbladder stones was calculated as 0.42% (3 to 721), 1.19% (3 to 252), 0.62% (2 to 325), 1.20% (14 to 1164) and 0.49% (27 to 5455), respectively (Table 3).
Table 3
Incidence of IGBCs in different gallbladder diseases
Gallbladder diseases
|
Number (%)
|
Cholecystitis
|
2 (0.62)
|
Gallbladder polyps
|
3 (0.42)
|
Gallbladder stones
|
27 (0.49)
|
Cholecystocholedocholithiasis
|
14 (1.20)
|
Biliary pancreatitis
|
3 (1.19)
|
Preoperative Radiology Of The Igbcs
All the IGBCs received ultrasonographic and MRI evaluation preoperatively. Diffuse thickening of the gallbladder with or without suspicion of malignancy and focal thickening of the gallbladder was observed in 2, 5 and 4 patients respectively through ultrasound examination. Furthermore, the suspicious lesion was observed in 2 patients. And 73.5% of the patients had unremarkable preoperative imaging during the ultrasonographic evaluation (Table 4). However, during the MRI examination, diffuse thickening of the gallbladder with or without suspicion of malignancy and focal thickening of the gallbladder were observed in 6, 3 and 8 patients respectively. Furthermore, 3 patients displayed the suspicious lesion. Overall, 59.2% of the patients had unremarkable preoperative MRI imaging (Table 4).
Table 4
Preoperative radiology of the IGBCs
Radiology Findings
|
Ultrasonography (Number,%)
|
MRI
(Number,%)
|
Diffuse suspicious thickening
|
2(4.1)
|
6(12.2)
|
Diffuse thickening not suspicious of malignancy
|
5(10.2)
|
3(6.1)
|
Focal Thickening
|
4(8.2)
|
8(16.3)
|
Suspicious lesion
|
2(4.1)
|
3(6.1)
|
Non specific
|
36(73.5)
|
29(59.2)
|
Surgical Information And Postoperative Pathology Of The Igbcs
Additionally, 47 patients underwent laparoscopic cholecystectomy or the following common bile duct exploration; 2 received only laparoscopic exploration due to peritoneal dissemination; 15 received intraoperative histological examination, among whom 14 were diagnosed with GBC intraoperatively and 11 received laparoscopic extensive resection after the cholecystectomy. Of the 33 cases diagnosed after LC, 12 received laparoscopic extensive resection and the rest received open extensive resection four weeks later. According to the pathological TNM classification system, the tumor stages of the IGBCs were pT1a (10 cases), pT1b (14 cases), pT2 (16 cases), pT3 (7 cases) and pT4 (2 cases). Regarding the pathological characteristics of tumors, one case was squamous cell carcinomas, two were papillary carcinoma, one was adenosquamous carcinoma and 45 were adenocarcinomas. Further, among the 45 adenocarcinomas patients, 13 were poorly differentiated, 13 were moderately differentiated, and 19 were well differentiated. The tumor stages and histopathological characteristics of IGBCs are listed in Table 5.
Table 5
Tumor stage and histopathological type of incidental gallbladder cancer
|
Intra-operative diagnosis
|
Post-operative diagnosis
|
Total
|
Tumor stage
|
|
|
|
T1a
|
3
|
7
|
10
|
T1b
|
2
|
12
|
14
|
T2
|
6
|
10
|
16
|
T3
|
3
|
4
|
7
|
T4
|
2
|
0
|
2
|
Histopathological type
|
|
|
|
Squamous cell carcinomas
|
0
|
1
|
1
|
Papillary carcinoma
|
0
|
2
|
2
|
Adenosquamous carcinoma
|
0
|
1
|
1
|
Adenocarcinomas
|
16
|
29
|
45
|